CCL2 and neoplasm: Liu et al. established a protein trap with CCL2 targeting ability to locally inhibit the CCL2 expression of tumor-associated adipocytes and thus lightened the immunosuppressive TME, which manifested as more abundant T cells and fewer M2 and myeloid-derived suppressor cells (MDSCs) [44].